Abbott (ABT) Tops Q4 EPS by 1c, Offers FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Abbott Labs (ABT) PT Raised to $68 at Leerink Partners
January 25, 2018 7:16 AM ESTLeerink Partners raised its price target on Abbott Labs (NYSE: ABT) to $68.00 (from $60.00) while maintaining a Outperform rating.
... MoreAbbott Labs (ABT) PT Raised to $71 at Stifel
January 24, 2018 4:42 PM ESTStifel raised its price target on Abbott Labs (NYSE: ABT) to $71.00 (from $63.00) while maintaining a Buy rating following strong Q4 results.
Analyst Rick Wise said the company has significant and sustainable momentum heading into 2018.
... MoreAbbott Labs (ABT) PT Raised to $67 at Evercore ISI
January 24, 2018 12:34 PM ESTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $67.00 (from $64.00) while maintaining a Outperform rating.
The firm raised FY2018 EPS from $2.82 to $2.87, trimmed FY 2019 from $3.23 to $3.22 and raised FY 2020 from $3.55 to $3.56.
... More